Exec Chat: Omron’s Hypertension Solutions Gain Traction With Shift To At-Home Patient Care
Omron is implementing its new VitalSight platform to physicians, hospitals for remote monitoring of high-risk hypertension patients at 50 US institutions and internationally.
You may also be interested in...
AliveCor is banking on continued telehealth growth during the pandemic and beyond by expanding its remote cardiology platform.
Minute Insight: Sema4 To Acquire Genomics Company GeneDx For $623M To Strengthen Clinical Data Platform
Genetic testing company Sema4 announced plans to buy GeneDx to strengthen Sema4’s health intelligence and genomic screening offers. The combined company is expected to generate $350m in pro forma 2022 revenue.
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the third day of the meeting.